- $684.52m
- $1.61bn
- $3.72bn
- 54
- 79
- 28
- 53
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,467 | 4,163 | 4,140 | 3,858 | 3,722 |
Cost of Revenue | |||||
Gross Profit | 973 | 954 | 1,002 | 840 | 834 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,495 | 4,242 | 4,109 | 3,901 | 3,943 |
Operating Profit | -2,028 | -79 | 31 | -43 | -221 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,106 | -139 | -25 | -127 | -332 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,934 | -118 | -28 | -182 | -296 |
Net Income Before Extraordinary Items | |||||
Net Income | -1,934 | -118 | -28 | -182 | -296 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,944 | -128 | -38 | -192 | -306 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.87 | -0.288 | 0.023 | -0.266 | -0.425 |